These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 6848402

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW, Lee YC, Kim MS, Lee SY, Bae SH, Choi JY, Yoon SK.
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H, Ayola B, Lok AS.
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [Abstract] [Full Text] [Related]

  • 7. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP, Lepiorz H, Berthold H, Gerok W.
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I, Liegl JM, Selmair H.
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of HBsAg-,HBeAg-positive chronic active hepatitis with adenine arabinoside. A case report with clinical remission and seroconversion to anti-HBs.
    Loeschke K, Abb J, Farack UM, Wiebecke B.
    Hepatogastroenterology; 1985 Aug; 32(4):178-80. PubMed ID: 2865200
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Determinants for hepatitis B e antigen clearance in chronic type B hepatitis.
    Liaw YF, Chu CM, Huang MJ, Sheen IS, Yang CY, Lin DY.
    Liver; 1984 Oct; 4(5):301-6. PubMed ID: 6503634
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.